CAD treatment needs to be individually tailored: Review study
Decisions about cold agglutinin disease (CAD) treatment need to be made on a case-by-case basis, considering each patient’s specific situation, a pair of scientists in Italy argued in a review study. The scientists reviewed available and up-and coming treatment options for CAD, giving advice for how best to employ…